---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-004285"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2024-03-28T23:59:59+00:00"
generated_at: "2026-06-04T06:03:43.916552+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Nutex Health reports Q4 net loss of $31.6M on $69.7M revenue; FY 2023 revenue up 13%

## Summary
- Q4 revenue $69.7M (+30% YoY); net loss $31.6M including $29.1M non-cash asset impairment.
- FY 2023 revenue $247.6M (+13% YoY); net loss $45.8M vs $424.8M in 2022.
- Adjusted EBITDA Q4 $3.1M (vs -$5.9M); FY $10.8M (vs $12.6M).
- Hospital division operating income $36.3M (+142%); net cash from operating activities $1.3M.
- Management initiated 2024 strategic plan for cost reduction and portfolio optimization.

## SEC filing metadata
- accession: 0001558370-24-004285
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2024-03-28T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000155837024004285/0001558370-24-004285-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000155837024004285/nutx-20240328x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-004285
- JSON: https://secwatch.observer/filing/0001558370-24-004285.json
- Plain text: https://secwatch.observer/filing/0001558370-24-004285.txt

## Key facts
- Earnings Releases
  Nutex Health Inc. reported financial results for the quarter ending December 31, 2023.
  - Period: the quarter ending December 31, 2023
  - Result: reported results
  source text: On March 28, 2024, Nutex Health Inc. (the “Company”) announced its financial and operating results for the quarter ending December 31, 2023. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479681/000155837024004285/0001558370-24-004285-index.htm
- Earnings Releases
  Nutex Health Inc. reported financial results for the year ended December 31, 2023.
  - Period: the year ended December 31, 2023
  - Result: reported results
  source text: On March 28, 2024, Nutex Health Inc. (the “Company”) announced its financial and operating results for the quarter ending December 31, 2023. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479681/000155837024004285/0001558370-24-004285-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.